Every month, MedicinMan in partnership with IMS Health, brings our readers the latest industry numbers related to sales and revenues of the top companies, brands and therapy areas in the Indian Pharmaceutical Market.
[su_dropcap style="flat" size="3" class=""]T[/su_dropcap]he Indian Pharmaceutical Market (IPM) was valued at Rs. 9162 crores in the month of June 2016 clocking a 9.6% growth over same period last year (SPLY). This is seen revival on track after a dip in growth observed in earlier months of 2016 post the ban imposed on 344 FDCs by the Government of India which affected the buying patterns in the market. On a MAT June basis, the industry was valued at Rs. 107,019 crores and reflected a 13% growth.
Free Membership Required
You must be a Free member to access this content.
